Modernizing Drug Enforcement Act of 2018
Latest action · Apr 30, 2018 Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedMar 15, 2018
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Modernizing Drug Enforcement Act of 2018
This bill deems a drug or substance that acts as an opioid mu receptor agonist (e.g., morphine) to be in schedule I of the Controlled Substances Act, subject to certain exceptions. A schedule I controlled substance is a drug, substance, or chemical that: has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.
Cosponsors 1
Members who signed on, in the order they did. All signed on Mar 15, 2018.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-NY | Thomas R. Suozzi | Original | Mar 15, 2018 |
Committees 2
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Mar 15, 2018 |
| Health Subcommittee | Referred Mar 16, 2018 | |
| House | Judiciary Committee | Referred Mar 15, 2018 |
| Crime and Federal Government Surveillance Subcommittee | Referred Apr 30, 2018 |
Actions 4
Everything that happened, newest first.
- Apr 30, 2018Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
- Mar 16, 2018Referred to the Subcommittee on Health.
- Mar 15, 2018Introduced in House
- Mar 15, 2018Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 164, no. 46, March 15, 2018, page H1652.
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To amend the Controlled Substances Act to deem drugs or other substances that act as opioid mu receptor agonists to be in schedule I, subject to exceptions for substances intended for legitimate medical or research use, and for other purposes.
- Short Titles as Introduced
- Modernizing Drug Enforcement Act of 2018
Subjects
Assigned by the Library of Congress. Policy area: Crime and Law Enforcement.
Text 1
Each version as it was printed, newest first.
- Mar 15, 2018Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.